[go: up one dir, main page]

DE60329185D1 - Impfstoff gegen piscirickettsiosis in lachsfischen basierend auf arthrobacter zellen - Google Patents

Impfstoff gegen piscirickettsiosis in lachsfischen basierend auf arthrobacter zellen

Info

Publication number
DE60329185D1
DE60329185D1 DE60329185T DE60329185T DE60329185D1 DE 60329185 D1 DE60329185 D1 DE 60329185D1 DE 60329185 T DE60329185 T DE 60329185T DE 60329185 T DE60329185 T DE 60329185T DE 60329185 D1 DE60329185 D1 DE 60329185D1
Authority
DE
Germany
Prior art keywords
piscirickettsiosis
cells
arthrobacteric
salmon fish
fish based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60329185T
Other languages
English (en)
Inventor
Kira Salonius
Steven Gareth Griffiths
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis Pharma GmbH Austria
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0216414.3A external-priority patent/GB0216414D0/en
Priority claimed from GB0220100A external-priority patent/GB0220100D0/en
Application filed by Novartis Pharma GmbH Austria, Novartis AG filed Critical Novartis Pharma GmbH Austria
Application granted granted Critical
Publication of DE60329185D1 publication Critical patent/DE60329185D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60329185T 2002-07-15 2003-07-14 Impfstoff gegen piscirickettsiosis in lachsfischen basierend auf arthrobacter zellen Expired - Fee Related DE60329185D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0216414.3A GB0216414D0 (en) 2002-07-15 2002-07-15 Organic compounds
GB0220100A GB0220100D0 (en) 2002-08-29 2002-08-29 Organic compounds
PCT/EP2003/007605 WO2004006953A2 (en) 2002-07-15 2003-07-14 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells

Publications (1)

Publication Number Publication Date
DE60329185D1 true DE60329185D1 (de) 2009-10-22

Family

ID=30117115

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329185T Expired - Fee Related DE60329185D1 (de) 2002-07-15 2003-07-14 Impfstoff gegen piscirickettsiosis in lachsfischen basierend auf arthrobacter zellen

Country Status (15)

Country Link
US (2) US7302913B2 (de)
EP (1) EP1523330B1 (de)
JP (1) JP4381977B2 (de)
CN (1) CN1292795C (de)
AT (1) ATE442162T1 (de)
AU (1) AU2003250944B2 (de)
BR (1) BR0312632B1 (de)
CA (1) CA2491524C (de)
DE (1) DE60329185D1 (de)
DK (1) DK1523330T3 (de)
ES (1) ES2330738T3 (de)
NO (1) NO338944B1 (de)
PT (1) PT1523330E (de)
SI (1) SI1523330T1 (de)
WO (1) WO2004006953A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008337440B2 (en) * 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
WO2013084169A2 (en) * 2011-12-07 2013-06-13 Yanez Carcamo Alejandro Javier Novel broth medium and blood-free solid media for the culture of the fish pathogen piscirickettsia salmonis
WO2015184130A1 (en) 2014-05-28 2015-12-03 Auburn University Vaccines for control of epidemic aeromonas hydrophila generated by markerless gene deletion
CN105039221B (zh) * 2015-08-07 2019-04-16 中国农业科学院哈尔滨兽医研究所 一株冷水鱼益生菌节杆菌菌株及其用途
CA3086603A1 (en) * 2017-12-21 2019-06-27 Gis Gas Infusion Systems Inc. Method and apparatus for fish farms
NO20200827A1 (en) * 2017-12-26 2020-07-14 Univ Chile Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs)
KR102200721B1 (ko) * 2019-11-18 2021-01-13 (주)애드바이오텍 연어 리케차성 패혈증 예방 또는 치료용 난황항체의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1100271A (zh) * 1994-04-12 1995-03-22 大连水产学院 鲤微生态制剂及其制备方法
US5871751A (en) * 1994-10-12 1999-02-16 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Renibacterium salmoninarum vaccine and method for its preparation
US6913754B1 (en) * 1997-01-30 2005-07-05 Novartis Ag Renibacterium salmoninarum vaccine
GB9701897D0 (en) * 1997-01-30 1997-03-19 Aqua Health Europ Ltd Vaccine
US20030165526A1 (en) * 1999-09-17 2003-09-04 Kuzyk Michael A. Vaccines and agents for inducing immunity against rickettsial diseases, and associated preventative therapy
GB0303507D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
AU2008337440B2 (en) * 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis

Also Published As

Publication number Publication date
CN1292795C (zh) 2007-01-03
CN1668328A (zh) 2005-09-14
PT1523330E (pt) 2009-09-29
HK1075840A1 (en) 2005-12-30
JP4381977B2 (ja) 2009-12-09
WO2004006953A2 (en) 2004-01-22
WO2004006953A3 (en) 2004-02-19
BR0312632B1 (pt) 2014-09-16
ES2330738T3 (es) 2009-12-15
CA2491524C (en) 2012-09-25
US7302913B2 (en) 2007-12-04
AU2003250944B2 (en) 2006-11-23
JP2005536500A (ja) 2005-12-02
HK1079100A1 (en) 2006-03-31
US20050129714A1 (en) 2005-06-16
US7707970B2 (en) 2010-05-04
BR0312632A (pt) 2005-04-19
EP1523330A2 (de) 2005-04-20
DK1523330T3 (da) 2009-11-23
US20090155313A1 (en) 2009-06-18
NO20050778L (no) 2005-02-14
AU2003250944A1 (en) 2004-02-02
CA2491524A1 (en) 2004-01-22
SI1523330T1 (sl) 2010-01-29
NO338944B1 (no) 2016-10-31
ATE442162T1 (de) 2009-09-15
EP1523330B1 (de) 2009-09-09

Similar Documents

Publication Publication Date Title
EP1579532A4 (de) Tragbare elektrische energiequelle
DE60326528D1 (de) Bipolare Batterie
DE10324396A8 (de) Brennstoffzelle
DE60334419D1 (de) Photovoltaische Zelle
DE60333852D1 (de) Brennstoffbatterie
EP1623164A4 (de) Kleinformatiges konzentrierendes solarchipsystem
NO20044141D0 (no) Elektrokjemiske brenselceller
EP1532517A4 (de) Batterieverwaltungssystem
DE60329024D1 (de) Brennstoffzelle
DE60325003D1 (de) Brennstoffzellenstruktur
ATE551742T1 (de) Wasserverwaltung in brennstoffzellen
DE60329185D1 (de) Impfstoff gegen piscirickettsiosis in lachsfischen basierend auf arthrobacter zellen
DE60303345D1 (de) Brennstoffzelle
EP1493104A4 (de) Gruppenverwaltung
NO20033872D0 (no) Undervanns grave- og sugeanordning
DE60042392D1 (de) Leistungsvorrichtung mit Schutz gegen unerwünschte Selbstaktivierung
DE60323022D1 (de) Brennstoffzelle
ATA7452002A (de) Kabeldurchführung
DE60334226D1 (de) Vakzine gegen infektiöse katzen-peritonitis
NO20041579L (no) Klostillende midler
EP1546769A4 (de) Umweltmässig verbesserte rückspiegelanordnung
ITMI20020869A0 (it) Generatore elettrochimico e membrana a ingombro ridotto
DE50310181D1 (de) Drosselklappeneinheit
SE0202795L (sv) Bränslecell och bränslecellsstack
DE60307688D1 (de) Hardware-unterstützter Tupelraum

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee